Heterocyclic derivatives and their use in the treatment of neurological disorders
US-9550758-B2 · Jan 24, 2017 · US
This page is not indexed by search engines while we improve data quality.
Badiger Sangamesh — Human Necessities
Badiger Sangamesh holds 3 patents in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Badiger Sangamesh |
| Technology | Human Necessities |
| Patents in slice | 3 |
| Recent patents in slice | 0 |
| First year | 2015 |
| Last year | 2017 |
Representative patents
Notable publications linking Badiger Sangamesh to Human Necessities.
Heterocyclic derivatives and their use in the treatment of neurological disorders
US-9550758-B2 · Jan 24, 2017 · US
Heterocyclic derivatives and their use in the treatment of neurological disorders
US-9550758-B2 · Jan 24, 2017 · US
Heterocyclic derivatives and their use in the treatment of neurological disorders
US-9550758-B2 · Jan 24, 2017 · US
Heterocyclic derivatives and their use in the treatment of neurological disorders
US-9550758-B2 · Jan 24, 2017 · US
Recent filings
Latest patents from Badiger Sangamesh in Human Necessities.
Heterocyclic derivatives and their use in the treatment of neurological disorders
US-9550758-B2 · Jan 24, 2017 · US
Heterocyclic derivatives and their use in the treatment of neurological disorders
US-9550758-B2 · Jan 24, 2017 · US
Heterocyclic derivatives and their use in the treatment of neurological disorders
US-9550758-B2 · Jan 24, 2017 · US
Heterocyclic derivatives and their use in the treatment of neurological disorders
US-9550758-B2 · Jan 24, 2017 · US
Heterocyclic derivatives and their use in the treatment of neurological disorders
US-9550758-B2 · Jan 24, 2017 · US
Related pages
Navigate to parent entity pages.